Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹7,896 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹7,896 Cr
Mar2024₹6,658 Cr
Mar2023₹5,986 Cr
Mar2022₹5,855 Cr
Mar2021₹6,056 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹7,896 Cr
18.59
Mar2024 ₹6,658 Cr
11.23
Mar2023 ₹5,986 Cr
2.23
Mar2022 ₹5,855 Cr
-3.32
Mar2021 ₹6,056 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹34,294.0 Cr -1.6% 3.7% 42.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,195.0 Cr 1.8% 9% 12.5% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 0.8% 0.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,725.0 Cr 2.8% 9.5% 45.4% Stock Analytics
CIPLA ₹116,467.0 Cr -1.2% 4.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,987.0 Cr -7.6% 0.1% 6.1% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-1.6%

3.7%

42.7%

SENSEX

-1%

4.4%

-8.3%


You may also like the below Video Courses